SU133422A1 - Medicinal product - rennet powder - Google Patents

Medicinal product - rennet powder

Info

Publication number
SU133422A1
SU133422A1 SU660682A SU660682A SU133422A1 SU 133422 A1 SU133422 A1 SU 133422A1 SU 660682 A SU660682 A SU 660682A SU 660682 A SU660682 A SU 660682A SU 133422 A1 SU133422 A1 SU 133422A1
Authority
SU
USSR - Soviet Union
Prior art keywords
rennet
powder
medicinal product
rennet powder
acute
Prior art date
Application number
SU660682A
Other languages
Russian (ru)
Inventor
Р.П. Комолова
Г.И. Кузнецова
Н.Н. Сафронова
Original Assignee
Р.П. Комолова
Г.И. Кузнецова
Н.Н. Сафронова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Р.П. Комолова, Г.И. Кузнецова, Н.Н. Сафронова filed Critical Р.П. Комолова
Priority to SU660682A priority Critical patent/SU133422A1/en
Application granted granted Critical
Publication of SU133422A1 publication Critical patent/SU133422A1/en

Links

Landscapes

  • Dairy Products (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

Сычужный Порошок: (сычужный фермент)  вл етс  препаратом протеолитических ферментов желудочно-кишечного тракта. Извлекаетс  из сЫчугов тел т и  гн т молочного возраста 10%-ным раствором поваренной соли и высаливаетс  прн помоши сол ной кислоты; до насто ш .его времени имел .применение только в сыроделии, В производстве сыроз.Rennet Powder: (rennet) is a preparation of proteolytic enzymes of the gastrointestinal tract. It is extracted from syringes from calves and milked from milky age with a 10% solution of sodium chloride and salted out with hydrochloric acid; up to the present time, it had only application in cheese making, in the production of cheese.

Применение сычужного порошка в качестве лечебного препарата при желудочно-кишечных заболевани х до сих пор не было известно.The use of rennet powder as a therapeutic agent for gastrointestinal diseases has not yet been known.

Установлено, что сычужный порошок (фермент)  вл етс  высокоактивным препаратОМ при лечении хронических и, острых заболеваний желудочно-кишечного тракта: острый гастрит, острый гастроэнтерит, острый гастроэнтероколит, .при лечении острой и хронической дезинтерии (после отмены антибиотиков), при хропических гастритах, при хронических колитах,  влени х дискензии, -при дуодените и т. п.Rennet powder (enzyme) has been found to be a highly active drug in the treatment of chronic and acute diseases of the gastrointestinal tract: acute gastritis, acute gastroenteritis, acute gastroenterocolitis, in the treatment of acute and chronic disintegration (after discontinuation of antibiotics), in tropical gastritis in chronic colitis, symptoms of dispensia, in duodenitis, etc.

Сычужный Порошок, предложенный в качестве лечебного препарата , примен етс  по следуюш,ей методике. Таблетки сычужного порошка весом 0,2 г принимаютс  во врем  еды три раза .в день по одной таблетке в,течение 1-2 мес цев; при т желых заболевани х дозировка увеличиваетс  до 3 таблеток на прием и курс лечени  .продлеваетс  до 3 мес цев; при острых заболевани х - по 1 таблетке 3 раза в день в течение 2-3 дней.Rennet Powder, proposed as a therapeutic drug, is applied according to the following procedure. Tablets of rennet powder weighing 0.2 g are taken during meals three times a day, one tablet per 1-2 months; with severe diseases, the dosage is increased to 3 tablets per dose and the course of treatment is extended up to 3 months; in case of acute diseases - 1 tablet 3 times a day for 2-3 days.

Препарат совершенно безвреден и невызывает никаких побочны.х  влений.The drug is completely harmless and does not cause any side effects.

Применение -в медицинской практике препарата «сычужный порошок разрешено Формакологическим Комитетом Министерства здравоохранени  СССР (протокол № 10 от 9 ма  1960 г.).Use in the medical practice of the drug “rennet powder is permitted by the Formological Committee of the USSR Ministry of Health (Minutes No. 10 dated May 9, 1960).

;Предмет изобретени ; Subject of the invention

Применение в медицинской практике «сычзжного порошка,  вл ющегос  Препаратом протеолитических ферментов желздочно-кишечлого тракта, дл  лечени  различных острых и хронических желудочно-кишечных заболеваний.Use in medical practice of "Syzhozhnogo powder, which is a preparation of proteolytic enzymes of the gastrointestinal tract, for the treatment of various acute and chronic gastrointestinal diseases.

SU660682A 1960-03-26 1960-03-26 Medicinal product - rennet powder SU133422A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU660682A SU133422A1 (en) 1960-03-26 1960-03-26 Medicinal product - rennet powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU660682A SU133422A1 (en) 1960-03-26 1960-03-26 Medicinal product - rennet powder

Publications (1)

Publication Number Publication Date
SU133422A1 true SU133422A1 (en) 1960-11-30

Family

ID=48404421

Family Applications (1)

Application Number Title Priority Date Filing Date
SU660682A SU133422A1 (en) 1960-03-26 1960-03-26 Medicinal product - rennet powder

Country Status (1)

Country Link
SU (1) SU133422A1 (en)

Similar Documents

Publication Publication Date Title
NO821832L (en) PROCEDURE FOR THE PREPARATION OF ALLERGIC Capsules
Spies et al. Pantothenic acid in human nutrition
BR112020000570A2 (en) propionic and / or butyric acid for use in the prophylactic and / or supportive therapeutic treatment of morbus parkinson
SU133422A1 (en) Medicinal product - rennet powder
JPS5938203B2 (en) A therapeutic agent for cerebral circulation disorders whose main ingredient is coenzyme Q.
Altemeier et al. Penicillin therapy in rat bite fever
FR2358893A1 (en) ANTIMICROBIAL COMPOSITION CONTAINING 1-IMIDAZOLYL-BUTANE-2-ONES OR -BUTANE-2-OLS HALOGENES
Hyman Anaphylactic shock after therapy with penicillinase
Miller et al. Treatment of enterobiasis with dithiazanine
SCHAEFER et al. Sodium gentisate in the treatment of acute rheumatic fever
ES2399269T3 (en) Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for skin treatment and other diseases of the exocrine gland
SILVERMAN et al. Toxic effects of diodoquin
SU263808A1 (en) Medical preparation
Hendricks et al. Spotted fever treated with para-aminobenzoic acid
GB950162A (en) Medicines for the treatment of hepatic disorders
Bach et al. Rheumatic fever
GB967871A (en) Anorexigenic compositions comprising ª‰-phenylisopropylamine derivatives
GB976096A (en) Pharmaceutical compositions
Javett et al. Acrodynia treated with D-penicillamine
RU2030179C1 (en) Antimicrobial and antifungous agent
Hayes et al. Fulminating meningococcemia (Waterhouse-Friderichsen syndrome): an unusual case with recovery following treatment with penicillin
JP2002265354A (en) Anti-helicobacter pylori agent composition
SU449724A1 (en) Mukaltin Expectorant
SU552085A1 (en) Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis
Davidson et al. The treatment of congenital syphilis with stovarsol